https://www.marketscreener.com/quote/stock/FRESH-TRACKS-THERAPEUTICS-65218214/news/Brickell-Biotech-Announces-Presentation-of-US-Phase-3-Open-Label-Long-Term-Safety-Study-Results-for-32988004/?utm_source=telegram&utm_medium=social&utm_campaign=share